HUP0300744A2 - Perfluoralkil-tartalmú komplexek cukorrészekkel, eljárás az elżállításukra és alkalmazásuk - Google Patents

Perfluoralkil-tartalmú komplexek cukorrészekkel, eljárás az elżállításukra és alkalmazásuk

Info

Publication number
HUP0300744A2
HUP0300744A2 HU0300744A HUP0300744A HUP0300744A2 HU P0300744 A2 HUP0300744 A2 HU P0300744A2 HU 0300744 A HU0300744 A HU 0300744A HU P0300744 A HUP0300744 A HU P0300744A HU P0300744 A2 HUP0300744 A2 HU P0300744A2
Authority
HU
Hungary
Prior art keywords
perfluoroalkyl
producing
same
sugar residues
containing complexes
Prior art date
Application number
HU0300744A
Other languages
English (en)
Inventor
Peter Mareski
Bernd Misselwitz
Ulrich Niedballa
Johannes Platzek
Bernd Radüchel
Hans-Joachim Weinmann
Original Assignee
Schering Ag.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag. filed Critical Schering Ag.
Publication of HUP0300744A2 publication Critical patent/HUP0300744A2/hu
Publication of HUP0300744A3 publication Critical patent/HUP0300744A3/hu

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/02—Acyclic radicals, not substituted by cyclic structures
    • C07H15/04—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/26—Acyclic or carbocyclic radicals, substituted by hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H23/00—Compounds containing boron, silicon, or a metal, e.g. chelates, vitamin B12

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

A találmány tárgyát (I) általános képletű, cukorrészeket hordozó,perfluoralkil-tartalmú fémkomplexek, az előállításukra szolgálóeljárás, valamint intravénás limfográfiára, tumordiagnosztikára ésinfarktus- és nekrózis leképezésére történő alkalmazásuk képezi. Az(I) általános képletben R jelentése 1-OH- vagy 1-SH-helyzetenkeresztül kapcsolódó mono- vagy oligoszacharid-maradék, Rf jelentéseegy perfluorozott szénlánc, K jelentése egy fémkomplex, G jelentéseegy legalább háromszorosan funkcionalizált csoport, Y és Zkapcsolócsoportokat jelentenek, m és 1 jelentése 1 vagy 2 és pjelentése 1-4. Ó
HU0300744A 2000-08-11 2001-07-23 Perfluoroalkyl-containing complexes comprising sugar residues, method for producing the same and use thereof HUP0300744A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10040381A DE10040381C1 (de) 2000-08-11 2000-08-11 Perfluoralkylhaltige Komplexe mit Zuckerresten, Verfahren zu deren Herstellung und ihre Verwendung
PCT/EP2001/008499 WO2002014309A1 (de) 2000-08-11 2001-07-23 Perfluoralkylhaltige komplexe mit zuckerresten, verfahren zu deren herstellung und ihre verwendung

Publications (2)

Publication Number Publication Date
HUP0300744A2 true HUP0300744A2 (hu) 2003-09-29
HUP0300744A3 HUP0300744A3 (en) 2009-01-28

Family

ID=7652861

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0300744A HUP0300744A3 (en) 2000-08-11 2001-07-23 Perfluoroalkyl-containing complexes comprising sugar residues, method for producing the same and use thereof

Country Status (31)

Country Link
EP (1) EP1307446B1 (hu)
JP (1) JP2004506631A (hu)
KR (1) KR100820387B1 (hu)
CN (1) CN1249058C (hu)
AR (1) AR035579A1 (hu)
AT (1) ATE293623T1 (hu)
AU (2) AU2001289729B2 (hu)
BG (1) BG107540A (hu)
BR (1) BR0113192A (hu)
CA (1) CA2418790A1 (hu)
CZ (1) CZ2003340A3 (hu)
DE (2) DE10040381C1 (hu)
DK (1) DK1307446T3 (hu)
EE (1) EE200300059A (hu)
ES (1) ES2240517T3 (hu)
HK (1) HK1062016A1 (hu)
HR (1) HRP20030172A2 (hu)
HU (1) HUP0300744A3 (hu)
IL (1) IL154328A0 (hu)
MX (1) MXPA03001285A (hu)
NO (1) NO20030648L (hu)
NZ (1) NZ524079A (hu)
PL (1) PL360359A1 (hu)
PT (1) PT1307446E (hu)
RU (1) RU2280644C2 (hu)
SK (1) SK1542003A3 (hu)
TW (1) TWI243170B (hu)
UA (1) UA75364C2 (hu)
WO (1) WO2002014309A1 (hu)
YU (1) YU10403A (hu)
ZA (1) ZA200301948B (hu)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19948651B4 (de) * 1999-09-29 2006-10-05 Schering Ag Para- und diamagnetische perfluorhaltige Verbindungen enthaltende galenische Formulierungen, deren Herstellung und Verwendung
US7344704B2 (en) 2002-07-10 2008-03-18 Schering Ag Use of perfluoroalkyl-containing metal complexes as contrast media in MR-imaging for visualization of intravascular thrombi
DE10231799B4 (de) * 2002-07-10 2006-10-05 Schering Ag Verwendung von perfluoralkylhaltigen Metallkomplexen als Kontrastmittel im MR-Imaging zur Darstellung von Intravasalen Thromben
DE10260372B4 (de) 2002-12-13 2007-01-04 Schering Ag Kernspintomographievorrichtung und Verfahren zur ortsaufgelösten Bilddarstellung
EP1904462A2 (de) * 2005-07-15 2008-04-02 Bayer Schering Pharma Aktiengesellschaft Perfluoralkylhaltige komplexe, verfahren zu deren herstellung, sowie deren verwendung
DE102006049821A1 (de) 2006-10-18 2008-04-24 Bayer Schering Pharma Aktiengesellschaft Metallchelate mit perfluoriertem PEG-Rest, Verfahren zu deren Herstellung, sowie deren Verwendung
BRPI0717395A2 (pt) * 2006-10-25 2013-10-15 Koninkl Philips Electronics Nv Composto para diagnosticar câncer de próstata em um indivíduo humano ou animal, composição farmacêutica, e, uso de um composto ou uma composição
DE102008024976A1 (de) 2008-05-23 2009-12-17 Marvis Technologies Gmbh Medizinisches Instrument
JP2011190183A (ja) * 2010-03-11 2011-09-29 Noguchi Institute フルオラス化糖結合型クラウンエーテル誘導体
EP2450067A1 (en) 2010-10-18 2012-05-09 MaRVis Technologies GmbH Medical device
EP2484388A1 (en) 2011-02-05 2012-08-08 MaRVis Technologies GmbH Implantable or insertable MRI-detectable medical device having a coating comprising paramagnetic ions and a process for preparing it
EP2692365A1 (en) 2012-08-03 2014-02-05 MaRVis Medical GmbH Implantable or insertable MRI-detectable medical device having a coating comprising paramagnetic ions and a process for preparing it
EP3101012A1 (en) 2015-06-04 2016-12-07 Bayer Pharma Aktiengesellschaft New gadolinium chelate compounds for use in magnetic resonance imaging
US10975060B2 (en) 2016-11-28 2021-04-13 Bayer Pharma Aktiengesellschaft High relaxivity gadolinium chelate compounds for use in magnetic resonance imaging
CN113164628A (zh) 2018-11-23 2021-07-23 拜耳股份有限公司 造影介质制剂及其制备方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5707604A (en) * 1986-11-18 1998-01-13 Access Pharmaceuticals, Inc. Vivo agents comprising metal-ion chelates with acidic saccharides and glycosaminoglycans, giving improved site-selective localization, uptake mechanism, sensitivity and kinetic-spatial profiles
AU623901B2 (en) * 1988-01-26 1992-05-28 Nycomed As Paramagnetic compounds comprising chelating moiety, linker group macro molecule and paramagnetic metal
EP0497926B1 (en) * 1989-10-23 1998-06-03 Nycomed Salutar, Inc. Multi-site metal chelating agents
US5330743A (en) * 1992-11-12 1994-07-19 Magnetic Research, Inc. Aminosaccharide contrast agents for magnetic resonance images
ZA958789B (en) * 1994-10-21 1996-05-29 Nihon Mediphysics Co Ltd Diagnostic imaging agent
DE19603033A1 (de) * 1996-01-19 1997-07-24 Schering Ag Perfluoralkylhaltige Metallkomplexe, Verfahren zu deren Herstellung und ihre Verwendung in der NMR-Diagnostik
DE19728954C1 (de) * 1997-06-30 1999-04-22 Schering Ag Saccharid-Konjugate, diese enthaltende pharmazeutische Mittel, Verfahren zu ihrer Herstellung und ihre Verwendung
DE19729013A1 (de) * 1997-07-03 1999-02-04 Schering Ag Oligomere, perfluoralkylhaltige Verbindungen, Verfahren zu deren Herstellung und ihre Verwendung in der NMR-Diagnostik
DE19744004C1 (de) * 1997-09-26 1999-07-22 Schering Ag Lipophile Metall-Komplexe für Nekrose und Infarkt-Imaging
DE19758105A1 (de) * 1997-12-18 1999-06-24 Schering Ag Dendritische Polymer-Saccharid-Konjugate, diese enthaltende pharmazeutische Mittel, Verfahren zu ihrer Herstellung und ihre Verwendung
DE19914101C1 (de) * 1999-03-22 2000-10-12 Schering Ag Perfluoralkylamide, ihre Herstellung und ihre Verwendung in der Diagnostik
DE19948651B4 (de) * 1999-09-29 2006-10-05 Schering Ag Para- und diamagnetische perfluorhaltige Verbindungen enthaltende galenische Formulierungen, deren Herstellung und Verwendung

Also Published As

Publication number Publication date
CA2418790A1 (en) 2003-02-07
DK1307446T3 (da) 2005-08-15
CN1468234A (zh) 2004-01-14
AU2001289729B2 (en) 2006-11-16
AU8972901A (en) 2002-02-25
EP1307446A1 (de) 2003-05-07
TWI243170B (en) 2005-11-11
DE50105965D1 (de) 2005-05-25
NZ524079A (en) 2005-10-28
SK1542003A3 (en) 2003-10-07
UA75364C2 (en) 2006-04-17
EP1307446B1 (de) 2005-04-20
HUP0300744A3 (en) 2009-01-28
NO20030648L (no) 2003-04-11
DE10040381C1 (de) 2002-06-06
MXPA03001285A (es) 2004-05-17
HRP20030172A2 (en) 2005-04-30
BR0113192A (pt) 2003-07-15
IL154328A0 (en) 2003-09-17
CN1249058C (zh) 2006-04-05
PL360359A1 (en) 2004-09-06
YU10403A (sh) 2006-05-25
PT1307446E (pt) 2005-08-31
ES2240517T3 (es) 2005-10-16
WO2002014309A1 (de) 2002-02-21
HK1062016A1 (en) 2004-10-15
NO20030648D0 (no) 2003-02-10
RU2280644C2 (ru) 2006-07-27
CZ2003340A3 (cs) 2003-09-17
ATE293623T1 (de) 2005-05-15
BG107540A (bg) 2003-11-28
EE200300059A (et) 2004-12-15
KR100820387B1 (ko) 2008-04-08
KR20030024855A (ko) 2003-03-26
AR035579A1 (es) 2004-06-16
JP2004506631A (ja) 2004-03-04
ZA200301948B (en) 2004-06-25

Similar Documents

Publication Publication Date Title
HUP0300744A2 (hu) Perfluoralkil-tartalmú komplexek cukorrészekkel, eljárás az elżállításukra és alkalmazásuk
DK0874645T3 (da) Perflouralkylholdige metalkomplekser og deres anvendelse i NMR-diagnostik
HUT60277A (en) Process for producing macrocyclic polychelate forming agents and their chelates, as well as diagnostics comprising the latter
FR2614020B1 (fr) Nouveaux ligands cycliques azotes, complexes metalliques formes par ces ligands, compositions de diagnostic contenant ces complexes et procede de preparation des ligands.
WO2002065395A3 (en) Analysis of successive data sets
CN106702292B (zh) 含N的无Be无Ni高硬Zr基块体非晶合金及制备方法
HUP0300769A2 (hu) Perfluoralkil-tartalmú komplexek poláros maradékokkal, eljárás az elżállításukra és alkalmazásuk
HU9601742D0 (en) Metalcomplexes of dendrimeric molecules, diagnostic agents containing them and process for producing the complexes and agents
Santi et al. Vibrational spectra of the copper (II) and nickel (II) complexes of piroxicam
BG93995A (bg) Хелати и комплекси на антибиотици с бивалентни и/или тривалентни метали, метод за получаването им и използването им за получаване на противоязвени средства
EP1601756A4 (en) METHODS AND COMPOSITIONS FOR TREATING CANCER AND INFECTIOUS DISEASES USING ALPHA (2) MACROGLOBULIN ANTIGEN MOLECULE COMPLEXES
AU2001234480A1 (en) Iron base high temperature alloy
ATE227781T1 (de) Austenitische ni-cr-mo-fe-legierung
JP2002294396A5 (hu)
HUP0100887A2 (hu) Bibapcitid-bázisú gyógyszerkészítmények trombusok leképezésére és kezelésére
Won et al. A Case of Clq Nephropathy in Steroid-Dependent Nephrotic Syndrome
SU414324A1 (ru) ЛИГАТУРА ДЛЯ ОБРАБОТКИ ЧУГУНАФОйд тт-?^ш
Zhang et al. Review of the Reactive Mechanism in Mechanical Alloying.
Bresciani et al. OSTRAKA DEMOTICI DA OSSIRINCO
Kay Correspondence re: Strictland-Marmol LB, Fessler RG, Rojiani AM. Necrotizing sarcoid granulomatosis mimicking an intracranial neoplasm: clinicopathologic features and review of the literature. Mod Pathol 2000; 13: 909-3.
Ma et al. Effect of rare earth La and chromium on pure copper's property.
Hu et al. The EDP characteristics of martensite twin substructure in high carbon steel
Xu et al. A Study on the as Forged High Toughness Microalloyed Medium Carbon Steel
Kim et al. The Properties of Cu--Al--Ni--X(X= Magnesium, Titanium) Shape Memory Alloy Produced by the HIP Process
Shao et al. Influence of hot deformation rate on structure and properties of low chromium semi steel

Legal Events

Date Code Title Description
FD9A Lapse of provisional protection due to non-payment of fees